MEN1112 (OBT357NF) is a humanized monoclonal antibody that selectively targets Bst1/CD157, with an EC50 value of 1 nM. It demonstrates significant antitumor activity against acute myeloid leukemia (AML) cells and holds potential for research into hematologic malignancies, including AML.
Target:
Others
* VAT and and shipping costs not included. Errors and price changes excepted
